Lv36
220 积分 2025-01-23 加入
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
1小时前
待确认
Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial
2小时前
已完结
Timing of Dialysis Initiation: When to Start? Which Treatment?
13天前
已完结
Role of Systemic Glucocorticoids in Reducing IgA and Galactose-Deficient IgA1 Levels in IgA Nephropathy
17天前
已关闭
IgA glycosylation and immune complex formation in IgAN
25天前
已完结
Dyslipidemia in Patients with Kidney Disease
28天前
已完结
Psoriasis: Which therapy for which patient
1个月前
已完结
Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models
1个月前
已完结
Tailored biological treatment for patients with moderate-to-severe psoriasis
1个月前
已完结
Biologics for psoriasis: is there any unmet need left?
1个月前
已完结
皖公网安备34019202002308
